Claris Lifesciences Jan-Mar quarter net dips 22% to Rs 10 cr

The company had posted a net profit of Rs 13.34 crore during the same period of previous fiscal

Press Trust of India New Delhi
Last Updated : May 22 2015 | 7:30 PM IST
Drug firm Claris Lifesciences today reported a 21.73 decline in its consolidated net profit at Rs 10.44 crore for the quarter ended March 31.

The Ahmedabad-based company had posted a net profit of Rs 13.34 crore during the same period of previous fiscal.

However, net sales of the company rose to Rs 154.72 crore during the January-March quarter, compared to Rs 133.09 crore during the same period of previous fiscal.
ALSO READ: Claris Lifesciences gains on injectible biz sale buzz

For the fiscal ended March 31, the company posted a net profit of Rs 149.47 crore, while the same stood at Rs 84.40 crore during the previous fiscal.

Net sales of the company, stood at Rs 780.11 crore, while the same stood at Rs 658.37 crore during the previous year.

The company said the results of the year were not comparable to the previous year due to shifting of its financial year reporting from this year.

Shares of Claris today ended at Rs 306.20 apiece on the BSE, down 1.32 per cent from previous close.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 22 2015 | 6:22 PM IST

Next Story